Eurobio Scientific Société anonyme (EPA:ALERS)
France
· Delayed Price · Currency is EUR 25.30
0.00 (0.00%)
May 14, 2025, 9:44 AM CET
EPA:ALERS Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | - | 49.3 | 47.49 | 92.92 | 65.1 | Upgrade
|
| Short-Term Investments | - | 39.73 | 38.44 | 9.47 | 0.46 | Upgrade
|
| Cash & Short-Term Investments | - | 89.03 | 85.94 | 102.39 | 65.56 | Upgrade
|
| Cash Growth | - | 3.60% | -16.07% | 56.18% | 760.44% | Upgrade
|
| Accounts Receivable | - | 26.94 | 32.78 | 43.86 | 51.21 | Upgrade
|
| Other Receivables | - | 3.74 | 6.09 | 8.32 | 5.52 | Upgrade
|
| Receivables | - | 30.67 | 38.87 | 52.18 | 56.73 | Upgrade
|
| Inventory | - | 21.45 | 21.65 | 16.29 | 12.93 | Upgrade
|
| Prepaid Expenses | - | 1.01 | 0.57 | 0.47 | - | Upgrade
|
| Other Current Assets | - | 1.39 | 1.53 | 2.27 | - | Upgrade
|
| Total Current Assets | - | 143.91 | 148.69 | 173.6 | 135.21 | Upgrade
|
| Property, Plant & Equipment | - | 12.3 | 12.66 | 10.05 | 9.92 | Upgrade
|
| Long-Term Investments | - | 3.6 | 3.6 | 3.6 | 0 | Upgrade
|
| Goodwill | - | 117.71 | 115.81 | 18.19 | 20.93 | Upgrade
|
| Other Intangible Assets | - | 2.52 | 1.97 | 2.29 | 3.84 | Upgrade
|
| Long-Term Deferred Charges | - | 32.9 | 37.2 | 1.28 | 1.66 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0 | 0 | Upgrade
|
| Total Assets | - | 316.33 | 330.73 | 209.87 | 172.3 | Upgrade
|
| Accounts Payable | - | 16.82 | 18.53 | 16.77 | 14.24 | Upgrade
|
| Accrued Expenses | - | 6.07 | 9.63 | 6.57 | 5.21 | Upgrade
|
| Current Portion of Long-Term Debt | - | 13.28 | 13.73 | 3.68 | 13.94 | Upgrade
|
| Current Portion of Leases | - | 1.8 | 1.6 | 1.56 | 1.5 | Upgrade
|
| Current Income Taxes Payable | - | 3.56 | 1.97 | 6.28 | 11.54 | Upgrade
|
| Current Unearned Revenue | - | 0.2 | 0.44 | 0.16 | 0.18 | Upgrade
|
| Other Current Liabilities | - | 2.64 | 1.25 | 1.05 | 1.39 | Upgrade
|
| Total Current Liabilities | - | 52.88 | 57.32 | 36.11 | 47.98 | Upgrade
|
| Long-Term Debt | - | 81.23 | 94.34 | 7.01 | 10.97 | Upgrade
|
| Long-Term Leases | - | 4.35 | 3.97 | 3.44 | 3.31 | Upgrade
|
| Other Long-Term Liabilities | - | 2.17 | 1.53 | 1.69 | 1.38 | Upgrade
|
| Total Liabilities | - | 141.16 | 157.75 | 49 | 64.45 | Upgrade
|
| Common Stock | - | 3.5 | 3.63 | 3.63 | 3.63 | Upgrade
|
| Additional Paid-In Capital | - | 33.57 | 40.05 | 40.05 | 40.05 | Upgrade
|
| Comprehensive Income & Other | - | 138.1 | 129.31 | 117.19 | 64.17 | Upgrade
|
| Total Common Equity | - | 175.17 | 172.98 | 160.87 | 107.85 | Upgrade
|
| Shareholders' Equity | - | 175.17 | 172.98 | 160.87 | 107.85 | Upgrade
|
| Total Liabilities & Equity | - | 316.33 | 330.73 | 209.87 | 172.3 | Upgrade
|
| Total Debt | - | 100.66 | 113.64 | 15.69 | 29.72 | Upgrade
|
| Net Cash (Debt) | - | -11.63 | -27.7 | 86.7 | 35.84 | Upgrade
|
| Net Cash Growth | - | - | - | 141.89% | - | Upgrade
|
| Net Cash Per Share | - | -1.04 | -2.44 | 7.97 | 3.18 | Upgrade
|
| Filing Date Shares Outstanding | - | 10.04 | 10.22 | 10.85 | 11.21 | Upgrade
|
| Total Common Shares Outstanding | - | 10.04 | 10.22 | 10.85 | 11.21 | Upgrade
|
| Working Capital | - | 91.03 | 91.37 | 137.49 | 87.23 | Upgrade
|
| Book Value Per Share | - | 17.44 | 16.92 | 14.83 | 9.62 | Upgrade
|
| Tangible Book Value | - | 54.94 | 55.21 | 140.39 | 83.08 | Upgrade
|
| Tangible Book Value Per Share | - | 5.47 | 5.40 | 12.94 | 7.41 | Upgrade
|
| Buildings | - | 1.33 | 0.88 | 0.85 | 0.71 | Upgrade
|
| Machinery | - | 0.76 | 1.12 | 1.12 | 8.5 | Upgrade
|
| Construction In Progress | - | 0.48 | 0.45 | 0.01 | 1.21 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.